The Clinical Evidence for the Safety and Efficacy of Marijuana in Humans, Second Edition, focuses on the effectiveness of cannabis in treating disorders that are related to the use of antiretrovirals. This article examines the safety and effectiveness of cannabis in treating AIDS-associated anorexia, levodopa-induced dyskinesias, and epilepsy.
Evidence for the efficacy and safety of cannabis in treating AIDS-associated anorexia
Evidence for the efficacy and safety of Cannabis in the treatment of AIDS-associated anorexia includes a prospective study that followed 874 HIV-infected adults for up to 18 months. Participants were asked whether they had used cannabis in the past two years, six months, or seven days. They were also asked how often they smoked cannabis and how frequently.
Effectiveness of cannabis in treating levodopa-induced dyskinesias
A recent study aimed to determine the effectiveness of cannabis in treating levodopopa-induced dyskinesiosis in patients with Parkinson’s disease. The researchers analyzed 17 patients with PD. Cannabis treatment was well tolerated, with no evidence of pro or antiparkinsonian effects. Furthermore, there were no improvements in secondary outcome measures. Moreover, the study showed that cannabis, particularly its component cannabidiol, did not improve dyskinesias, or the symptoms associated with them. If you want to buy Cannabis delivery Halifax, you can contact with atlanticgreencross.com.
Safety of cannabis in treating epilepsy
Research on the safety of cannabis in treating epilepsy is limited by many factors. Most studies have involved small numbers of patients, and THC is psychoactive. As such, clinical trials involving large numbers of patients are rare. Even when the drug is used properly, however, some preclinical studies have shown that it may produce pro-convulsive effects, especially at low doses. Further, there is evidence that cannabis may cause seizures in patients with recessive genetic mutations. Moreover, cannabis may contain impurities and other harmful chemicals.
Effectiveness of cannabis in treating addiction
To assess the effectiveness of cannabis in addiction treatment, researchers analyzed the outcomes of twenty-one studies. These included a randomized controlled trial, a preclinical study, and a randomized control trial. The primary outcome of these studies was the number of days participants used illicit cannabis during a 12-week period. Secondary outcomes included alternate cannabis use and health status. In the four-week follow-up interviews, participants were evaluated according to their use of Weed delivery Halifax.
Safety of cannabis in treating cancer
Although there are no conclusive data that show the effectiveness of cannabis for the treatment of cancer, there are many studies that indicate that it can help with certain types of cancer. One such study looked at 68 patients who had stage IV non-small cell lung cancer. Of these patients, 34 had cancer and used cannabis while receiving immunotherapy. While the patients who used cannabis were significantly less likely to receive immunotherapy as a first or second-line treatment, they did show statistically significant differences when compared to their non-cannabis-no-cannabis-no-cash-based counterparts. These cancer cells responded differently to the treatment than did the non-users, and their median time to tumor progression was significantly shorter than those of non-users.
